IMforte shows lurbinectedin plus atezolizumab maintenance extends PFS and OS in extensive-stage SCLC, with manageable cytopenias and key patient-selection guidance.
Zacks Investment Research on MSN
Novocure's Optune Lua gets Japan reimbursement for NSCLC treatment
Novocure NVCR recently announced that Japan’s Ministry of Health, Labour and Welfare has approved reimbursement for Optune ...
Everyday Health on MSN
How to manage LEMS weakness while treating lung cancer
Learn how to tell the difference between these two common symptoms.
Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did ...
Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.
Scientists have developed an AI system that analyzes complex gene-expression signatures to estimate the likelihood that a tumor will spread.
John Avlon talks with Annabelle Gurwitch about surviving stage-4 lung cancer—and what her experience reveals about America’s broken health system.
Fred Hutch Cancer Center scientists have developed an experimental strategy to give genetically engineered CAR T cells help they'd normally find within lymph nodes — but on the go, within the tumor.
Health Notes is an occasional listing of health happenings around Louisiana. Have something you'd like to share? Contact us at margaret.delaney@theadvocate.com.
The experience features surgical robotic technology designed to assist with lung cancer diagnosis and treatment. Lung cancer is often found in patients aged 65 and older. Dr. Angel Nunez, a ...
A team of researchers at VCU Massey Comprehensive Cancer Center has identified a new pathway through which mutations in the tumor suppressor p53 gene—found very frequently in human tumors—hijack DNA ...
In this summary of a panel discussion at the 2026 TTLC Meeting, Dr Estelamari Rodriguez highlights key takeaways from a multidisciplinary conversation on early-stage lung cancer m ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results